{
 "PrintNo":"S6818","Session":2023,"Chamber":"SENATE","BillType":"Senate","Published":"2023-05-10T15:17:28.442432Z",
 "Status":"IN_SENATE_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2024-01-03","Committee":"Insurance"}],
 "Actions":[
  {"Text":"REFERRED TO INSURANCE","Date":"2023-05-10","Chamber":"SENATE"},
  {"Text":"REFERRED TO INSURANCE","Date":"2024-01-03","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":1520,"Name":"Nathalia Fernandez","Short":"FERNANDEZ"}],
 "Title":"Includes individuals treated with opioid partial agonist treatment medication as being in an opioid treatment program for the purposes of certain insurance coverage and co-payments",
 "Summary":"Includes individuals treated with opioid partial agonist treatment medication as being in an opioid treatment program for the purposes of certain insurance coverage and co-payments.",
 "LawSection":"Insurance Law","LawCode":"Amd §§3216, 3221 & 4303, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to including individuals treated with opioid partial agonist treatment medication as being in an opioid treatment program for the purposes of certain insurance coverage and co-payments"
}